BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

PDS Biotechnology Corporation 



Indianapolis  Indiana    U.S.A.
Phone: 513-475-6610 Fax: 513-221-1891


SEARCH JOBS










 Company News
PDS Biotechnology Corporation Announces Appointment Of Biotech Industry Leader Sir Richard Sykes To Its Board Of Directors As Executive Chairman 12/18/2014 9:17:16 AM
NetScientific Invests In Next Generation, Immunotherapeutics Company, PDS Biotechnology Corporation 12/15/2014 8:53:15 AM
PDS Biotechnology Corporation Announces Treatment Of First Patient With PDS0101 Based On The Novel Versamune™ Cancer Immunotherapy Platform In A Phase 1 Clinical Trial 2/11/2014 10:02:51 AM
PDS Biotechnology Corporation Signs Worldwide Licensing Agreement With Merck KGaA (MKGAF.PK) for Versamune™ 7/9/2012 7:35:43 AM
PDS Biotechnology Corporation Awarded $1.28M National Cancer Institute Contract 3/2/2010 8:53:57 AM
PDS Biotechnology Corporation Demonstrates Pre-Clinical Safety of its Versamune(TM)-Based HPV Product 10/6/2009 8:54:32 AM
PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG 2/24/2009 11:00:18 AM
PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies 11/7/2008 7:41:08 AM